Literature DB >> 21454676

Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.

Nurlan Dauletbaev1, Daniel Eklove, Nadir Mawji, Michele Iskandar, Sergio Di Marco, Imed-Eddine Gallouzi, Larry C Lands.   

Abstract

Down-regulation of overabundant interleukin (IL)-8 present in cystic fibrosis (CF) airways could ease excessive neutrophil burden and its deleterious consequences for the lung. IL-8 production in airway epithelial cells, stimulated with e.g. inflammatory cytokines IL-1β and tumor necrosis factor (TNF)-α, is regulated by several signaling pathways including nuclear factor (NF)-κB and p38 mitogen-activated protein kinase (MAPK). We previously demonstrated that the anti-inflammatory drugs dexamethasone and ibuprofen suppress NF-κB; however, only dexamethasone down-regulates cytokine-induced IL-8, highlighting the importance of non-NF-κB mechanisms. Here, we tested the hypothesis that down-regulation of cytokine-induced IL-8 requires modulation of the MAPK phosphatase (MKP)-1/p38 MAPK/mRNA stability pathway. The effects of dexamethasone (5 nm) and ibuprofen (480 μm) on this pathway and IL-8 were studied in CF (CFTE29o-, CFBE41o-) and non-CF (1HAEo-) airway epithelial cells. We observed that dexamethasone, but not ibuprofen, destabilizes IL-8 mRNA and up-regulates MKP-1 mRNA. Further, siRNA silencing of MKP-1, via p38 MAPK, leads to IL-8 overproduction and diminishes the anti-IL-8 potential of dexamethasone. However, MKP-1 overexpression does not significantly alter IL-8 production. By contrast, direct inhibition of p38 MAPK (inhibitor SB203580) efficiently suppresses IL-8 with potency comparable with dexamethasone. Similar to dexamethasone, SB203580 decreases IL-8 mRNA stability. Dexamethasone does not affect p38 MAPK activation, which excludes its effects upstream of p38 MAPK. In conclusion, normal levels of MKP-1 are necessary for a full anti-IL-8 potential of pharmacological agents; however, efficient pharmacological down-regulation of cytokine-induced IL-8 also requires direct effects on p38 MAPK and mRNA stability independently of MKP-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454676      PMCID: PMC3091209          DOI: 10.1074/jbc.M110.205724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Grain dust induces IL-8 production from bronchial epithelial cells: the effect of dexamethasone on IL-8 production.

Authors:  H S Park; J H Suh; H Y Kim; O J Kwon; D C Choi
Journal:  Ann Allergy Asthma Immunol       Date:  1999-04       Impact factor: 6.347

2.  Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines.

Authors:  D Kube; U Sontich; D Fletcher; P B Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-03       Impact factor: 5.464

3.  Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8.

Authors:  C Taggart; R J Coakley; P Greally; G Canny; S J O'Neill; N G McElvaney
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

4.  Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells.

Authors:  A A Stecenko; G King; K Torii; R M Breyer; R Dworski; T S Blackwell; J W Christman; K L Brigham
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

Review 5.  Regulation of interleukin-8 gene expression.

Authors:  K A Roebuck
Journal:  J Interferon Cytokine Res       Date:  1999-05       Impact factor: 2.607

6.  Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells.

Authors:  M M Chang; M Juarez; D M Hyde; R Wu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-01       Impact factor: 5.464

Review 7.  Oral steroids for cystic fibrosis.

Authors:  K Cheng; D Ashby; R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.

Authors:  H C Lai; S C FitzSimmons; D B Allen; M R Kosorok; B J Rosenstein; P W Campbell; P M Farrell
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

9.  Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction.

Authors:  S D Sagel; R Kapsner; I Osberg; M K Sontag; F J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

10.  Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase.

Authors:  S Kumar; M S Jiang; J L Adams; J C Lee
Journal:  Biochem Biophys Res Commun       Date:  1999-10-05       Impact factor: 3.575

View more
  16 in total

1.  Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1.

Authors:  N Dauletbaev; K Herscovitch; M Das; H Chen; J Bernier; E Matouk; J Bérubé; S Rousseau; L C Lands
Journal:  Br J Pharmacol       Date:  2015-10       Impact factor: 8.739

2.  Regulation of interleukin-6 secretion by the two-pore-domain potassium channel Trek-1 in alveolar epithelial cells.

Authors:  Andreas Schwingshackl; Bin Teng; Manik Ghosh; Keng Gat Lim; Gabor Tigyi; Damodaran Narayanan; Jonathan H Jaggar; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-28       Impact factor: 5.464

3.  A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion.

Authors:  Neil Warner; Aaron Burberry; Maria Pliakas; Christine McDonald; Gabriel Núñez
Journal:  J Biol Chem       Date:  2014-08-28       Impact factor: 5.157

4.  Roles for the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, in feedback control of inflammatory gene expression and repression by dexamethasone.

Authors:  Suharsh Shah; Elizabeth M King; Ambika Chandrasekhar; Robert Newton
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

Review 5.  The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis.

Authors:  Athanasios Mavropoulos; Eirini I Rigopoulou; Christos Liaskos; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Dev Immunol       Date:  2013-09-12

6.  Effect of erythropoietin on primed leucocyte expression profile.

Authors:  Mirko Pesce; Paolo Felaco; Sara Franceschelli; Lorenza Speranza; Alfredo Grilli; Maria Anna De Lutiis; Alessio Ferrone; Vittorio Sirolli; Mario Bonomini; Mario Felaco; Antonia Patruno
Journal:  Open Biol       Date:  2014-06       Impact factor: 6.411

7.  TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.

Authors:  Elena Lesma; Silvia Ancona; Silvia M Sirchia; Emanuela Orpianesi; Vera Grande; Patrizia Colapietro; Eloisa Chiaramonte; Anna Maria Di Giulio; Alfredo Gorio
Journal:  J Cell Mol Med       Date:  2014-03-07       Impact factor: 5.310

8.  p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity.

Authors:  Athanasios Mavropoulos; Timoklia Orfanidou; Christos Liaskos; Daniel S Smyk; Vassiliki Spyrou; Lazaros I Sakkas; Eirini I Rigopoulou; Dimitrios P Bogdanos
Journal:  Autoimmune Dis       Date:  2013-07-10

9.  Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.

Authors:  Laura M Campbell; Pamela J Maxwell; David J J Waugh
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-06

10.  Rhinovirus Load Is High despite Preserved Interferon-β Response in Cystic Fibrosis Bronchial Epithelial Cells.

Authors:  Nurlan Dauletbaev; Mithun Das; Maria Cammisano; He Chen; Sareen Singh; Cora Kooi; Richard Leigh; Trevor Beaudoin; Simon Rousseau; Larry C Lands
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.